Agenda - Day 1 – Tuesday, 16 Sept 2025

Key Sessions

Jessica Federer

Investing in Biotech Breakthroughs: A VC Outlook

Angelini Ventures

Ruchira Glaser

Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare

Novartis

Lei Meng

Series A Secured, What's Next? Scaling Your Biotech

Bain Capital Life Sciences

Scott DeWire

The Art of the Acquisition: Redefining Pharma’s Future Through M&A

Boehringer Ingelheim

Jason Hafler

Funding Biotech Innovation: The CVC Perspective

Sanofi Ventures

Mike Patten

New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025

Harbour BioMed

Day 1 – Tuesday, 16 Sept 2025Tuesday, September 16, 2025 - ET (Eastern Time, GMT-05:00)

Showing 1 of 1 Streams

Biotech Leaders Morning Keynote Plenary

9:00am - 9:05am

LSX Welcome Address

9:05am - 9:55am

Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare

Ruchira Glaser - Chief Medical Office & Global Head of Clinical Development, Novartis
Maha Radhakrishnan - Executive Partner, Sofinnova Investments
Kiran Reddy - Managing Director, Blackstone Life Sciences
Mary Schaheen - President, Prevail Partners
Geeta Vemuri - Founder and Managing Partner, Agent Capital

9:55am - 10:30am

Fireside Chat: Opportunities and Challenges Ahead for Biopharma – Looking to 2026

Showing 3 of 3 Streams

Biotech Leaders Capital Markets & Investment

Biotech Leaders Partnerships & Deal Making

Biotech Leaders Business Strategies & Market Opportunities

11:00am - 11:50am

Investing in Biotech Breakthroughs: A VC Outlook

Jessica Federer - Board Member, Angelini Ventures
Hal Paz - Operating Partner, Khosla Ventures
Soyoung Park - General Partner, 1004 Venture Partners
Sally Wang Liang - Managing Partner, Xpanse Venture

11:50am - 12:40pm

Funding Biotech Innovation: The CVC Perspective

Jason Hafler - Managing Director, Sanofi Ventures
Marian Nakada - VP, Venture Investments, JJDC
Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
Cookie Yu - Investment Director, Samsung Ventures

11:00am - 11:50am

Partnerships That Pay Off: The Blueprint for Biopharma Success

Jon Kiburz - VP Transactions, R&D Business Development, GSK
Laura Collins - Senior Director, Transactions, Business Development, AstraZeneca
Clare Fisher - SVP BD and M&A, BeiGene
Anu Connor - VP, Head of Oncology External Innovation, IPSEN

11:50am - 12:40pm

Licensing Goldmines: Turning Intellectual Property into Biotech Success

Carla Bauer - Director, Oncology S&E, BD&L, Merck
Swarna Balasubramanian - Associate Director, S&E, BD&L, AstraZeneca
Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka Pharmaceuticals

11:00am - 11:50am

From Molecules to Millions: How to Build a Biotech Powerhouse

Scott Saywell - EVP, Corporate Development, Coherus BioSciences
Paul Bresge - CEO, Ray Therapeutics
Joe Goldberg - National Life Sciences Industry Consulting Leader, RSM US LLP
Milenko Cicmil - CEO & Co-Founder, Tasca Therapeutics
Rich Yang - CEO, Biolinq

11:50am - 12:40pm

Unlocking AI’s Full Potential to Transform Drug Discovery & Development

Julie Frearson - SVP Chief Scientific Officer, Charles River Laboratories

Showing 3 of 3 Streams

Biotech Leaders Capital Markets & Investment

Biotech Leaders Partnerships & Deal Making

Biotech Leaders Business Strategies & Market Opportunities

1:40pm - 2:30pm

Beyond the Pitch: Landing Early-Stage VC Funding

Mahesh Narayanan - Managing Partner, Neuvation Ventures
Salar Roshan - Operating Partner, 3E Bioventures Capital
Giles Hamilton - Operating Partner, New Growth Advisors

2:30pm - 3:20pm

Series A Secured, What's Next? Scaling Your Biotech

Lei Meng - Managing Director, Life Sciences, Bain Capital Life Sciences
Evan Caplan - Principal, OrbiMed
Jamil Bag - Partner, SV Health Investors
John Boyce - Managing Director and Co-Founder, TigerGene

1:40pm - 2:30pm

Collaborating for Innovation: The Role of Research Partnerships in Biotech

Simone Mori - Program Leader - External Research Venture, Moderna
Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
Alicia Zhou - CEO, Cancer Research Institute
Peng Leong - CBO and Therapeutic Area Head, Brain Aging, BioAge
Alfred Slanetz - Chairman, National Foundation for Cancer Research

2:30pm - 3:20pm

Sealing the Deal: Powering Autoimmune Breakthroughs Through Strategic Investment & Partnerships

Laura Tadvalkar - Managing Director, RA Capital
Saifur Rahman - Senior Director Business Development & Licensing, Sanofi
John Mayfield - SVP, Business Development & Strategy, Flagship Pioneering
Paul Oppold - VP, Investments & Head of Coporate Development, Roivant Sciences

1:40pm - 2:30pm

New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025

Mike Patten - Chief Strategy Officer, Harbour BioMed
Michael Choi - Chief Business & Strategy Officer, CStone Pharmaceuticals
Armin Rump - Associate Director, Global Business Development, Otsuka Pharmaceutical
Osamu Nakanishi - President, KISSEI AMERICA, INC.

2:30pm - 3:20pm

Talent for Tomorrow: How to Leverage a Hybrid Workforce for Innovation and Growth

Erik Fink - Managing Partner & Co-CEO, Slone Partners
Christine Horton - CEO, Visura Technologies
Sam Windsor - CEO, Ignota Labs

Day 1 – Tuesday, 16 Sept 2025Tuesday, September 16, 2025 - ET (Eastern Time, GMT-05:00)

Get the Latest Event Updates